Survival analyses of different treatment modalities and clinical stage for hypopharyngeal carcinoma

Medicine and Dentistry

• Clinical Stage 100%
• Hypopharynx Carcinoma 100%
• Survival Analysis 100%
• Failure Free Survival 100%
• Treatment Modality 100%
• Chemoradiotherapy 75%
• Overall Survival 50%
• Distant Metastasis 50%
• Progression Free Survival 50%
• Local Failure Free Survival 37%
• Group Therapy 12%
• Tumor 12%
• Diseases 12%

Keyphrases

• Survival Analysis 100%
• Treatment Modalities 100%
• Hypopharyngeal Carcinoma 100%
• Failure-free Survival 100%
• Definitive Chemoradiotherapy (dCRT) 54%
• Distant Metastasis 36%
• Regional Failure 36%
• Overall Survival 27%
• Local Failure 27%
• Progression-free Survival 27%
• Survival Outcomes 18%
• Definitive Surgery 18%
• Tumor 9%
• No Significant Difference 9%
• Kaplan-Meier 9%
• Baseline Characteristics 9%
• Survival Benefit 9%
• Therapy Groups 9%
• Stage III Disease 9%
• T Classification 9%
• Overall Survival Progression-free Survival 9%